has built up an enviable reputation as a source of high-level information and market analysis; a forum for high-level debate; a melting pot of innovative approaches to industry problems and, of course, incomparable networking opportunities. World-class conference content and speakers are the driving force behind the success of IBIS conferences. IBIS consistently delivers groundbreaking thought-leading presentations on a wide range of issues that consistently receive outstanding feedback from delegates. Whether it is a local Forum event, a larger Regional or the Global Summit itself, IBIS looks at the present and future opportunities and challenges to give all delegates a competitive edge. ̽»¨¾«Ñ¡ will once again be attending IBIS as an exhibitor, in addition to having a speaking engagement. We look forward to seeing you at IBIS! Need to schedule a meeting with a sales representative? Contact us today.
More stories
̽»¨¾«Ñ¡ Predicts 2021 Trends in Its Fourth Quarter 2020 Industry Trends Report
According to ̽»¨¾«Ñ¡ experts, 2021 will see growth in personal vehicle ownership and electric vehicles, rising accident severity and increasing automation and digitization in the claims process.
GM and ̽»¨¾«Ñ¡ Launch GM Collision Repair Network in Canada
New program focuses on increasing brand loyalty and customer confidence by promoting the proper, safe repair of Chevrolet, Buick, GMC and Cadillac vehicles.
Episode 1: Re-Imagining What's Possible in a Pandemic
Ryan and Tony Cotto, director of auto and underwriting policy at National Association of Mutual Insurance Companies (NAMIC), discuss the impact of COVID-19 on automotive insurers. Learn how carriers have quickly adapted to a new normal and how they’re re-imagining the future of claims post-pandemic.
FDA Authorizes Use of First at Home COVID-19 Test Kit
The test takes about 30 minutes and an indicator light will note a positive or negative result.
Bamlanivimab Granted Emergency Use Authorization For Early COVID-19 Treatment
Bamlanivimab is an investigational monoclonal antibody treatment that has shown promise in treating mild-to-moderate COVID-19 infections.
FDA Approves Veklury (Remdesivir) for Treatment of Hospitalized COVID-19 Patients
Learn about how the approval may affect the workers' compensation industry.